ATE401879T1 - Disulfiram enthaltende arzneimittel - Google Patents

Disulfiram enthaltende arzneimittel

Info

Publication number
ATE401879T1
ATE401879T1 AT99900280T AT99900280T ATE401879T1 AT E401879 T1 ATE401879 T1 AT E401879T1 AT 99900280 T AT99900280 T AT 99900280T AT 99900280 T AT99900280 T AT 99900280T AT E401879 T1 ATE401879 T1 AT E401879T1
Authority
AT
Austria
Prior art keywords
drugs containing
disulfiram
containing disulfiram
angiogenesis
useful
Prior art date
Application number
AT99900280T
Other languages
English (en)
Inventor
Moshe Marikovsky
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE401879T1 publication Critical patent/ATE401879T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AT99900280T 1998-01-11 1999-01-11 Disulfiram enthaltende arzneimittel ATE401879T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL12289298A IL122892A0 (en) 1998-01-11 1998-01-11 Pharmaceutical compositions comprising a thiocarbamate

Publications (1)

Publication Number Publication Date
ATE401879T1 true ATE401879T1 (de) 2008-08-15

Family

ID=11071076

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99900280T ATE401879T1 (de) 1998-01-11 1999-01-11 Disulfiram enthaltende arzneimittel

Country Status (9)

Country Link
US (1) US6288110B1 (de)
EP (1) EP1047416B1 (de)
JP (1) JP2002500180A (de)
AT (1) ATE401879T1 (de)
AU (1) AU1888599A (de)
DE (1) DE69939155D1 (de)
DK (1) DK1047416T3 (de)
IL (1) IL122892A0 (de)
WO (1) WO1999034784A2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548540B2 (en) 1998-09-08 2003-04-15 Charlotte-Mecklenburg Hospital Authority Method of treating cancer using dithiocarbamate derivatives
US7816403B2 (en) * 1998-09-08 2010-10-19 University Of Utah Research Foundation Method of inhibiting ATF/CREB and cancer cell growth and pharmaceutical compositions for same
US6706759B1 (en) 1998-09-08 2004-03-16 Charlotte-Mecklenburg Hospital Authority Method of treating cancer using dithiocarbamate derivatives
US6589987B2 (en) * 1998-09-08 2003-07-08 Charlotte-Mecklenburg Hospital Authority Method of treating cancer using tetraethyl thiuram disulfide
AU2002226650A1 (en) * 2001-01-18 2002-07-30 Arnold Hoffman Redox therapy for tumors
US20040157837A1 (en) * 2002-11-07 2004-08-12 Serbedzija George N. Combinations for the treatment of fungal infections
ATE552837T1 (de) * 2005-12-02 2012-04-15 Univ Johns Hopkins Verwendung von hochdosierten oxazaphosphorin- arzneimitteln zur behandlung von immunstörungen
WO2008034074A2 (en) 2006-09-15 2008-03-20 The Johns Hopkins University Cyclosphosphamide in combination with anti-idiotypic vaccines
WO2008034071A2 (en) 2006-09-15 2008-03-20 The Johns Hopkins University Method of identifying patients suitable for high-dose cyclophosphamide treatment
WO2008034076A2 (en) 2006-09-15 2008-03-20 The Johns Hopkins University Cyclophosphamide in combination with immune therapeutics
US20100099757A1 (en) * 2006-12-04 2010-04-22 Yossef Israeli-Shalev Disulfiram doses and treatment regimen suitable for treatment of angiogenesis-dependent disorders
WO2009067699A2 (en) * 2007-11-21 2009-05-28 Accentia Biopharmaceuticals, Inc. Methods for providing a system of care for an oxazaphosphorine drug regimen
US9026372B2 (en) * 2007-11-21 2015-05-05 Accentia Biopharmaceuticals, Inc. Methods for providing a system of care for a high-dose oxazaphosphorine drug regimen
EP2632450A1 (de) * 2010-08-31 2013-09-04 Avidal Vascular GmbH Zusammensetzungen mit einem taxan zur beschichtung von medizinischen vorrichtungen
JP6206939B2 (ja) * 2011-10-11 2017-10-04 国立大学法人 千葉大学 肝がん幹細胞阻害剤
US10369108B2 (en) 2013-03-15 2019-08-06 Mylan Laboratories, Inc. Hot melt granulation formulations of poorly water-soluble active agents
WO2015120254A1 (en) * 2014-02-06 2015-08-13 Texas Tech University System Disulfiram compositions and treatments for brain tumors
GB201407806D0 (en) * 2014-05-02 2014-06-18 Ucl Business Plc Treatment of fibrosis
GB201519643D0 (en) * 2015-11-06 2015-12-23 Univ Wolverhampton Disulfiram formulation
US10828271B2 (en) 2016-04-13 2020-11-10 University Of Wolverhampton Method for treating pleuroperitoneal membrane cancers by locally injecting disulfiram preparation
EP3311843A1 (de) 2016-10-13 2018-04-25 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Zusammensetzungen enthaltend dithiocarbamat und cyclodextrin
EP3597221B1 (de) 2017-03-17 2023-08-30 Osaka University Mittel zur behandlung von netzhautdegenerationen und von erkrankungen in zusammenhang mit lichtaufnahme
CA3103432A1 (en) * 2018-06-27 2020-01-02 Children's Medical Center Corporation Compounds for inhibition of inflammation
US11311538B2 (en) 2018-07-13 2022-04-26 Yale University Compositions and methods for targeting cancers
EP3693740A1 (de) 2019-02-07 2020-08-12 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Verbesserte dithiocarmabatbasierende verbindungen, therapien und diagnostik
KR20210049403A (ko) * 2019-10-25 2021-05-06 연세대학교 산학협력단 암의 예방 또는 치료용 조성물
AU2021254780A1 (en) * 2020-04-16 2022-10-20 Atossa Therapeutics, Inc. Compositions and methods to reduce the infectivity of a virus
WO2021231814A1 (en) * 2020-05-14 2021-11-18 The Trustees Of Columbia University In The City Of New York Compositions and methods for the treatment and prevention of vascular malformations
US11033516B1 (en) * 2020-09-18 2021-06-15 Spring Discovery, Inc. Combination therapies with disulfiram
WO2022061171A1 (en) * 2020-09-18 2022-03-24 Spring Discovery, Inc. Combination therapies with disulfiram
CN114376997B (zh) * 2021-10-10 2023-04-28 深圳市人民医院 一种新型IRE1a抑制剂紫草素及与双硫仑协同抗肿瘤组合方式

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870101A (en) * 1987-03-17 1989-09-26 Merrell Dow Pharmaceuticals Inc. Method of inhibiting interleukin-1 release
EP0284879A3 (de) * 1987-03-17 1990-10-17 Merrell Dow Pharmaceuticals Inc. Verfahren zur Hemmung der Freisetzung von Interleukin-1
US5807884A (en) * 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases

Also Published As

Publication number Publication date
WO1999034784A2 (en) 1999-07-15
EP1047416A2 (de) 2000-11-02
DK1047416T3 (da) 2008-11-17
DE69939155D1 (de) 2008-09-04
WO1999034784A3 (en) 2000-09-08
US6288110B1 (en) 2001-09-11
IL122892A0 (en) 1998-08-16
AU1888599A (en) 1999-07-26
EP1047416B1 (de) 2008-07-23
JP2002500180A (ja) 2002-01-08

Similar Documents

Publication Publication Date Title
ATE401879T1 (de) Disulfiram enthaltende arzneimittel
IT1212739B (it) Composti eterociclici in cui l'eterosostituente e'ossigeno,zolfo,so,s o2 oppure nr2,utili nel trattamento delle neoplasie e dermatosi
EE9700008A (et) Uus ravimpreparaat valu vaigistamiseks
FI922325A (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
HK48897A (en) An external analgesic lotion and method of making
KR890000101A (ko) 반월조직의 치료 개선방법 및 치료약제
DE69308290D1 (de) Vorsehen einer optimierten schrittmacherfrequenz, die mit den physiologischen erfordernissen des patienten variiert
NO996314L (no) Fremgangsmåte for behandling av tobakk for å redusere innholdet av nitrosamin og produkter fremstilt av denne
BR0014996A (pt) Método para prevenir ou melhorar a dor de um ferimento fechado cirurgicamente em um indivìduo, e, emplastro
FR2771004B1 (fr) Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
DE3588023D1 (de) Mittel zur Behandlung von Herzerkrankungen.
IT240192Y1 (it) Apparecchiatura per l'esfoliazione dello stato corneo dell'epidermidee la rivitalizzazione della pelle
DE69426690T2 (de) Behandlung von atrophischer Haut und Vagina
ATA47787A (de) Festes mundpflegemittel gegen zahnstein und mundgeruch
DE69424777T2 (de) 3,4-diarylchromane zur behandlung von dermatitis
DE68913739D1 (de) Kosmetische und hautbehandlungs-zusammensetzungen.
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
KR890000097A (ko) 항레트로비루스 작용을 갖는 당단백질 처리 억제제
DE69924979D1 (de) Behandlung von chronischen schmerzen
DE59904042D1 (de) Medikament zur prophylaxe und/oder behandlung des mammarkarzinoms enthaltend einen steroidalen aromataseinhibitor
NO960545D0 (no) Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin
WO1999034763A3 (en) Pharmaceutical compositions comprising thiram for inhibiting angiogenesis
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
KR930702016A (ko) 골다공증 치료제
ATE230608T1 (de) Verwendung von bradykinin-antagonisten zur herstellung von arzneimitteln zur behandlung und prävention der alzheimer'schen krankheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties